ATNM

1.56

3.11% -0.05

Handel nachbörslich: 1.54 -0.02 -1.28%

Actinium Pharmaceuticals Inc (ATNM)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.61

Offen:

$1.61

24-Stunden-Volumen:

183.64K

Relative Volume:

1.13

Marktkapitalisierung:

$48.67M

Einnahmen:

$81,000

Nettoeinkommen (Verlust:

$-41.04M

KGV:

-1.1846

EPS:

-1.3169

Netto-Cashflow:

$-30.69M

1W Leistung:

-1.27%

1M Leistung:

-4.29%

6M Leistung:

+18.18%

1J Leistung:

-11.36%

1-Tages-Spanne:

$1.53

$1.61

1-Wochen-Bereich:

$1.47

$1.61

52-Wochen-Spanne:

$1.06

$2.41

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Firmenname

Actinium Pharmaceuticals Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (636)

Telefon

646-767-3870

Adresse

275 Madison Avenue, 7th Floor, New York, NY

Mitarbeiter

Twitter

@actiniumpharma

Nächster Verdiensttermin

2025-08-08

Neueste SEC-Einreichungen

ATNM's Discussions on Twitter

Vergleichen Sie ATNM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ATNM Actinium Pharmaceuticals Inc	1.56	50.23M	81,000	-41.04M	-30.69M	-1.3169
VRTX Vertex Pharmaceuticals Inc	412.22	104.45B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	469.36	60.95B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	572.60	59.11B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	812.95	49.23B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.94	35.92B	4.56B	-176.77M	225.30M	-1.7177

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-07	Herabstufung	B. Riley Securities	Buy → Neutral
2024-05-14	Eingeleitet	Stephens	Overweight
2023-09-06	Eingeleitet	HSBC Securities	Buy
2023-02-21	Herabstufung	William Blair	Outperform → Mkt Perform
2022-09-08	Eingeleitet	Cantor Fitzgerald	Overweight
2022-08-25	Eingeleitet	B. Riley Securities	Buy
2020-11-05	Eingeleitet	Alliance Global Partners	Buy
2017-12-06	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-10-23	Fortgesetzt	ROTH Capital	Buy
2017-09-14	Eingeleitet	Maxim Group	Buy
2016-08-25	Eingeleitet	ROTH Capital	Buy
2016-02-29	Eingeleitet	H.C. Wainwright	Buy
2015-10-15	Eingeleitet	FBR Capital	Outperform
2014-10-01	Eingeleitet	MLV & Co	Buy
2014-07-22	Eingeleitet	Canaccord Genuity	Buy

Alle ansehen

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

Oct 13, 2025

Actinium Pharmaceuticals (ATNM) Reveals Promising Data for NSCLC Treatment - GuruFocus

Oct 13, 2025

Actinium Shares Rise After Preclinical Data for ATNM-400 Show Potent Anti-Tumor Activity in Lung Cancer Models - MarketScreener

Oct 13, 2025

Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire

Oct 13, 2025

What high frequency data says about Actinium Pharmaceuticals Inc.Breakout Watch & Technical Entry and Exit Tips - newser.com

Oct 13, 2025

Is Actinium Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

Oct 13, 2025

Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire

Oct 13, 2025

Oct 12, 2025

Is Actinium Pharmaceuticals Inc. (Delaware) stock a contrarian opportunityMarket Risk Report & AI Powered Market Trend Analysis - newser.com

Oct 12, 2025

Oct 10, 2025

Can Actinium Pharmaceuticals Inc. recover in the next quarter2025 Risk Factors & Expert Approved Trade Ideas - newser.com

Oct 10, 2025

Why Actinium Pharmaceuticals Inc. (7AY1) stock remains stableWeekly Trading Summary & Verified Momentum Watchlists - newser.com

Oct 10, 2025

Will Actinium Pharmaceuticals Inc. (Delaware) stock beat international competitionInflation Watch & AI Forecasted Stock Moves - newser.com

Oct 10, 2025

Oct 09, 2025

How geopolitical risks impact Actinium Pharmaceuticals Inc. (7AY1) stockSell Signal & High Return Stock Watch Alerts - newser.com

Oct 09, 2025

Exit strategy if you’re trapped in Actinium Pharmaceuticals Inc.Market Weekly Review & High Conviction Buy Zone Picks - newser.com

Oct 09, 2025

Oct 06, 2025

Will Actinium Pharmaceuticals Inc. stock remain a Wall Street favoritePrice Action & Real-Time Volume Trigger Notifications - newser.com

Oct 06, 2025

Will Actinium Pharmaceuticals Inc. stock recover faster than marketJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com

Oct 06, 2025

Short interest data insights for Actinium Pharmaceuticals Inc.IPO Watch & Risk Managed Investment Signals - newser.com

Oct 06, 2025

Does Actinium Pharmaceuticals Inc. show high probability of rebound2025 Historical Comparison & Risk Managed Trade Strategies - newser.com

Oct 06, 2025

Oct 05, 2025

How big funds are accumulating Actinium Pharmaceuticals Inc. (7AY1) stockQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com

Oct 05, 2025

How Actinium Pharmaceuticals Inc. (7AY1) stock performs in volatility spikesRate Cut & Real-Time Volume Analysis - newser.com

Oct 05, 2025

Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com

Oct 05, 2025

Oct 03, 2025

Actinium Pharmaceuticals Inc. stock trend forecast2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com

Oct 03, 2025

Oct 02, 2025

How to use Fibonacci retracement on Actinium Pharmaceuticals Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com

Oct 02, 2025

Oct 01, 2025

Published on: 2025-10-01 07:40:56 - newser.com

Oct 01, 2025

Sep 30, 2025

Is Actinium Pharmaceuticals Inc a good long term investmentTechnical Analysis Insights & Trusted Financial Advisors at No Cost - earlytimes.in

Sep 30, 2025